AbbVie (ABBV) shares dip for 7th day, but analysts see buying opportunity after recent setback in schizophrenia drug trials.

On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

THURSDAY, Nov. 14, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

CNET Survey: Holiday Shoppers May Have $291 in Deliveries at Risk of Theft ...

Electric vehicle sales in the September quarter plunged by more than 25 per cent as many government rebates valued up to $6,000 came to an end.

From the end of November Market data will no longer be displayed here.